TVARDI THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
TVARDI THERAPEUTICS, INC. (TVRD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.58 million shares for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2015-08-10
- TVARDI THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-03-31 was 1.29M shares, a 44.31% increase year-over-year.
- TVARDI THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2014-03-31 was 897.01K shares, a 92.73% decline year-over-year.
- TVARDI THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2013-03-31 was 12.34M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2015-06-30 | 1.58M shares 10-Q · filed 2015-08-10 | ||
| 2015-03-31 | 1.29M shares 10-Q · filed 2015-05-12 | ||
| 2014-09-30 | 964.36K shares 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | 1.08M shares 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 897.01K shares 10-Q · filed 2015-05-12 | ||
| 2013-09-30 | 13.06M shares 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | 1.15M shares 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | 12.34M shares 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |